Commodore Capital LP - 30 Sep 2025 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX)

Filing Manager: Commodore Capital LP
Reporting Manager: Commodore Capital LP
Security: Celldex Therapeutics, Inc. Common Stock, par value $.001
Symbol: CLDX
Shares outstanding: 65.8M shares
Disclosed Ownership: 3.03M shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 17:08:02 UTC
Date of event: 30 Sep 2025
Previous filing: 10 Apr 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Commodore Capital LP	4.6%	3.03M	0	3.03M	Michael Kramarz	Managing Partner
Commodore Capital Master LP	4.6%	3.03M	0	3.03M	Michael Kramarz	Authorized Signatory